Basic Materials / Specialty ChemicalsNSE
$197.90
+7.20 (+3.78%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 27% · confianza 25%
FCF escenarios
weak_data · normalized FCF $12.9B · quality 37.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
39/100
D
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$66.6B
P/E
22.1x
↑EV/EBITDA
6.9x
↓ROE
0.6%
↑Gross Margin
40.4%
↑Debt/Equity
1.32
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-7.0%
FCF CAGR
+6.0%
FCF margin
2.6%
FCF / Net income
10.27x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $167.91B · net income $425.2M · FCF $4.37B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $167.91B | $167.91B | $152.67B | $180.52B | $209.06B |
| Net Income | $425.2M | $425.2M | $-5.64B | $-9.38B | $14.39B |
| EBITDA | $22.41B | $22.41B | $14.88B | $10.88B | $35.97B |
| EPS | 1.26 | 1.26 | -16.78 | -27.89 | 42.77 |
| Gross Margin | 40.4% | 40.4% | 39.9% | 36.5% | 43.9% |
| Operating Margin | 7.3% | 7.3% | 3.0% | 5.0% | 13.6% |
| Net Margin | 0.3% | 0.3% | -3.7% | -5.2% | 6.9% |
| Balance Sheet | |||||
| Debt/Equity | 1.32 | 1.32 | 1.28 | 1.18 | 1.15 |
| Cash Flow | |||||
| Free Cash Flow | $4.37B | $4.37B | $12.90B | $24.68B | $3.67B |
| Returns | |||||
| ROE | 0.6% | 0.6% | -8.5% | -12.8% | 17.1% |
| Valuation | |||||
| P/E | 22.09 | 22.09 | — | — | 4.05 |
| EV/EBITDA | 6.94 | 6.94 | 8.85 | 11.42 | 4.00 |
| P/B | 0.89 | 0.89 | 0.90 | 0.70 | 0.69 |
| Growth & Yield | |||||
| Revenue Growth | 10.0% | 10.0% | -15.4% | -13.7% | — |
| EPS Growth | 107.5% | 107.5% | 39.8% | -165.2% | — |
| Dividend Yield | 0.5% | 0.5% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
140.7%
EPS terminal req.
$17.56
Spread vs growth
-33.1%
5Y implied EPS CAGR
76.0%
EPS terminal req.
$21.25
Spread vs growth
31.6%
10Y implied EPS CAGR
39.1%
EPS terminal req.
$34.22
Spread vs growth
68.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+39.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-16.78 → 1.26
Residual
+38.5%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.